Johnson & Johnson $JNJ Stake Raised by Colonial Trust Advisors

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Colonial Trust Advisors grew its stake in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 3.8% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 129,264 shares of the company's stock after purchasing an additional 4,735 shares during the period. Johnson & Johnson makes up about 1.9% of Colonial Trust Advisors' holdings, making the stock its 10th largest position. Colonial Trust Advisors' holdings in Johnson & Johnson were worth $21,437,000 as of its most recent filing with the SEC.

Other institutional investors also recently made changes to their positions in the company. Highline Wealth Partners LLC boosted its position in shares of Johnson & Johnson by 51.8% in the 1st quarter. Highline Wealth Partners LLC now owns 252 shares of the company's stock worth $42,000 after buying an additional 86 shares in the last quarter. Stone House Investment Management LLC purchased a new stake in shares of Johnson & Johnson in the 1st quarter worth about $47,000. von Borstel & Associates Inc. purchased a new stake in shares of Johnson & Johnson in the 1st quarter worth about $49,000. Harvest Fund Management Co. Ltd purchased a new stake in shares of Johnson & Johnson in the 1st quarter worth about $52,000. Finally, Capital A Wealth Management LLC purchased a new stake in shares of Johnson & Johnson in the 4th quarter worth about $50,000. 69.55% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

JNJ has been the topic of several recent research reports. UBS Group boosted their price objective on shares of Johnson & Johnson from $180.00 to $190.00 and gave the stock a "buy" rating in a research report on Thursday, July 17th. Piper Sandler restated an "overweight" rating on shares of Johnson & Johnson in a report on Thursday, July 17th. Benchmark upgraded shares of Johnson & Johnson to a "strong-buy" rating in a report on Thursday, April 24th. Royal Bank Of Canada upped their target price on shares of Johnson & Johnson from $181.00 to $185.00 and gave the company an "outperform" rating in a report on Thursday, July 17th. Finally, Morgan Stanley upped their target price on shares of Johnson & Johnson from $171.00 to $176.00 and gave the company an "equal weight" rating in a report on Thursday, July 17th. Nine analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Johnson & Johnson presently has an average rating of "Moderate Buy" and a consensus target price of $174.50.

Johnson & Johnson Trading Down 0.2%

NYSE JNJ opened at $176.26 on Tuesday. Johnson & Johnson has a 12 month low of $140.68 and a 12 month high of $177.57. The company has a 50-day moving average of $161.70 and a 200-day moving average of $158.60. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.01 and a quick ratio of 0.76. The company has a market cap of $424.49 billion, a P/E ratio of 18.85, a P/E/G ratio of 2.25 and a beta of 0.41.

Johnson & Johnson (NYSE:JNJ - Get Free Report) last posted its quarterly earnings data on Wednesday, July 16th. The company reported $2.77 EPS for the quarter, beating analysts' consensus estimates of $2.68 by $0.09. Johnson & Johnson had a net margin of 25.00% and a return on equity of 32.49%. The company had revenue of $23.74 billion during the quarter, compared to the consensus estimate of $22.85 billion. During the same quarter in the prior year, the company posted $2.82 EPS. The company's quarterly revenue was up 5.8% compared to the same quarter last year. As a group, equities analysts predict that Johnson & Johnson will post 10.58 earnings per share for the current year.

Johnson & Johnson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 9th. Investors of record on Tuesday, August 26th will be given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend is Tuesday, August 26th. Johnson & Johnson's dividend payout ratio is 55.61%.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.